[1] 张毅,季媛媛,任晓静,等.HBV感染患者临床类型与免疫功能的相关性及临床意义.肝脏,2018,23:402-404. [2] Xibing G,Xiaojuan Y,Zhonghua L,et al.Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance.Hepat Mon,2011,11:810-815. [3] 王哲,解红霞.对慢性乙型肝炎早期肝硬化病人血清NK细胞、TGF-β1水平及肝纤维化的临床分析.内蒙古医科大学学报,2018,40:488-491,495. [4] Holder KA,Comeau EM,Grant MD.Origins of natural killer cell memory:special creation or adaptive evolution.Immunology,2018,154:38-49. [5] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19:389-400. [6] Scheuer P J.Classification of chronic viral hepatitis: a need for reassessment.J Hepatol,1991,13:372-374. [7] 郭飞波.慢性乙肝患者血清补体C3、C4与肝炎分级程度以及肝纤维化程度的关系研究.中国免疫学杂志,2017,33:426-428,432. [8] Yang Y,Han Q,Hou Z,et al.Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.Cell Mol Immunol,2017,14:465-475. [9] 殷智颖, 张野,徐土炳.慢性乙型肝炎患者外周血NK细胞杀伤细胞凝集素样受体G1表达及其对NK细胞杀伤功能的影响.实用肝脏病杂志,2020,23:175-178. [10] 赵小瑜, 周妮,汤永志,等.HBV相关肝病患者外周血NK细胞PD-1、Tim-3表达及意义.医学研究杂志,2017,46:51-54,59. [11] El Sharkawy R,Thabet K,Lampertico P,et al.A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.Aliment Pharmacol Ther,2018,48:564-573. [12] 潘志耘,曹淑凤,黄睿,等.慢性乙型肝炎患者不同免疫状态及抗病毒治疗早期外周血NK细胞亚群变化特点.胃肠病学和肝病学杂志,2017,26:444-448. [13] 郭飞波.慢性乙肝患者血清补体C3、C4与肝炎分级程度以及肝纤维化程度的关系研究.中国免疫学杂志,2017,33:426-428,432. [14] Zheng B,Yang Y,Han Q,et al.STAT3 directly regulates NKp46 transcription in NK cells of HBeAg-negative CHB patients.J Leukoc Biol,2019,106:987-996. [15] 邹勇,林哲生,陈玉婵,等.过表达B7-H6在自然杀伤细胞介导的肝细胞凋亡中的作用.中国病理生理杂志,2017,33:2095-2098. [16] 程明,孙汭,田志刚,等.人类肝脏NK细胞与肝脏疾病.中国免疫学杂志,2020,36:1281-1290. [17] Zhao J,Li Y,Jin L,et al.Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients.PLoS One,2012,7:e49135. |